Press Releases | Association for Accessible Medicines

AAM Statement - President Trump’s Blueprint to Lower Drug Prices

Jun 22, 2018 | Rachel Schwartz

AAM Announces Additional 2018 Associate Members

Jun 22, 2018 | Rachel Schwartz

AAM Announces New Regular Member and Board Member

Senate Judiciary Committee Markup - CREATES Act

Jun 14, 2018 | Rachel Schwartz

AAM Statement on Senate Judiciary Committee Vote on CREATES Act

IGBA Joins ICH Management Committee

Jun 7, 2018 | Rachel Schwartz

IGBA Joins ICH Management Committee and Welcomes the Positive Vote of the General Assembly

May 31, 2018 | Rachel Schwartz

AAM Statement on FDA REMS Guidance

May 22, 2018 | Rachel Schwartz

AAM Receives Platinum and Gold Recognition from Hermes Creative Awards

May 22, 2018 | Rachel Schwartz

AAM Statement on Avalere Medicare Analysis

Amicus brief Restasis

May 18, 2018 | Jeff Francer

AAM Files Brief to Oppose Pharmaceutical Company Abuse of the Patent System

May 17, 2018 | Rachel Schwartz

Transparency an Important Step in Ending the Shenanigans

May 16, 2018 | Rachel Schwartz

AAM Announces Additional 2018 Associate Members

Generics & Proposed China Tariffs

May 14, 2018 | Rachel Schwartz

AAM’s Comments on USTR’s Proposed China Tariffs

May 14, 2018 | Rachel Schwartz

Tara Ryan Joins AAM as Vice President, State Government Affairs